Franchi Jean M.
Insider CIK 1653053 · MACK Chief Financial Officer · BDSX Director · DMTX Chief Financial Officer · REPL Chief Financial Officer · IRON Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | S Sale | 2026-04-14 | 2026-04-15 | 6,257 | $69.24 | $433.2K | 64,333 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-04-13 | 2026-04-15 | 400 | $69.00 | $27.6K | 70,590 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-02-25 | 2026-02-27 | 353 | $69.06 | $24.4K | 70,990 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 3,397 | $65.01 | $220.8K | 75,027 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 3,684 | $65.89 | $242.7K | 71,343 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 4,075 | $62.86 | $256.2K | 78,424 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2026-02-10 | 2026-02-11 | 25,500 | — | $0 | 25,500 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2026-02-10 | 2026-02-11 | 19,000 | — | $0 | 82,499 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2026-01-02 | 2026-01-06 | 6,354 | — | $0 | 6,354 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2026-01-02 | 2026-01-06 | 8,164 | — | $0 | 8,164 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-07-17 | 2025-07-18 | 2,031 | $59.00 | $119.8K | 63,499 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 2,000 | $57.50 | $115.0K | 65,530 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-06-16 | 2025-06-18 | 2,000 | $52.26 | $104.5K | 67,530 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2025-05-20 | 2025-05-22 | 92,429 | — | $0 | 92,429 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2025-05-20 | 2025-05-22 | 42,010 | — | $0 | 42,010 | SEC↗ |
| BDSX BIODESIX INC | M Exercise deriv | 2025-04-01 | 2025-04-02 | 26,368 | — | $0 | 0 | SEC↗ |
| BDSX BIODESIX INC | M Exercise | 2025-04-01 | 2025-04-02 | 26,368 | — | $0 | 108,140 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 3,136 | $54.58 | $171.2K | 69,530 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 36,000 | — | $0 | 36,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2025-02-10 | 2025-02-12 | 36,000 | — | $0 | 72,666 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2024-05-21 | 2024-05-23 | 60,766 | — | $0 | 60,766 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2024-05-21 | 2024-05-23 | 37,050 | — | $0 | 37,050 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-02-07 | 2024-02-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2024-02-07 | 2024-02-15 | 36,666 | — | $0 | 36,666 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2024-01-01 | 2024-01-03 | 105,389 | — | $0 | 145,811 | SEC↗ |
| BDSX BIODESIX INC | A Award | 2023-08-03 | 2023-08-07 | 61,728 | $1.62 | $100.0K | 81,772 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2023-05-23 | 2023-05-25 | 40,422 | — | $0 | 40,422 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-05-16 | 2023-05-18 | 11,351 | $18.05 | $204.9K | 128,748 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 67,500 | — | $0 | 67,500 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2023-04-01 | 2023-04-04 | 45,000 | — | $0 | 140,099 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2023-01-03 | 2023-01-05 | 7,317 | — | $0 | 153,150 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2023-01-01 | 2023-01-04 | 62,500 | — | $0 | 145,833 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2022-05-24 | 2022-05-26 | 83,333 | — | $0 | 83,333 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2022-05-16 | 2022-05-18 | 3,436 | $14.59 | $50.1K | 95,099 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 78,750 | — | $0 | 78,750 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2022-04-01 | 2022-04-05 | 52,500 | — | $0 | 98,535 | SEC↗ |
| BDSX BIODESIX INC | M Exercise deriv | 2022-03-31 | 2022-04-04 | 20,044 | — | $0 | 0 | SEC↗ |
| BDSX BIODESIX INC | M Exercise | 2022-03-31 | 2022-04-04 | 20,044 | — | $0 | 20,044 | SEC↗ |
| BDSX BIODESIX INC | A Award deriv | 2021-06-29 | 2021-07-01 | 20,044 | — | $0 | 20,044 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 69,050 | — | $0 | 69,050 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2021-04-01 | 2021-04-05 | 46,035 | — | $0 | 46,035 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-14 | 2021-01-15 | 14,900 | — | $0 | 140,000 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-14 | 2021-01-15 | 600 | $44.00 | $26.4K | 0 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-14 | 2021-01-15 | 14,300 | $44.55 | $637.1K | 600 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-14 | 2021-01-15 | 14,900 | $14.08 | $209.8K | 14,900 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-13 | 2021-01-15 | 100 | — | $0 | 154,900 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 100 | $44.19 | $4.4K | 0 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-13 | 2021-01-15 | 100 | $14.08 | $1.4K | 100 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-12-14 | 2020-12-16 | 25,000 | — | $0 | 155,000 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-12-14 | 2020-12-16 | 25,000 | $14.08 | $352.0K | 25,000 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 389 | $42.09 | $16.4K | 0 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 17,856 | $43.70 | $780.3K | 7,144 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 6,755 | $42.86 | $289.5K | 389 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2020-04-01 | 2020-04-02 | 56,350 | — | $0 | 56,350 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2019-12-09 | 2019-12-11 | 180,000 | — | $0 | 180,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2018-12-11 | 2018-12-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2018-02-15 | 2018-02-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2017-08-24 | 2017-08-28 | 450,000 | — | $0 | 450,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-02-01 | 2017-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |